Matsumoto S | Pharmacology Research Laboratories Astellas Pharma Inc.

スポンサーリンク

概要

関連著者

もっと見る

著作論文

Direct Comparison of the Pharmacodynamics of Four Antifungal Drugs in a Mouse Model of Disseminated Candidiasis Using Microbiological Assays of Serum Drug Concentrations
Determination of Antifungal Activities in Serum Samples from Mice Treated with Different Antifungal Drugs Allows Detection of an Active Metabolite of Itraconazole
New Antitumor Substances, FR901463, FR901464 and FR901465 II. Activities against Experimental Tumors in Mice and Mechanism of Action
Synthesis and Biological Properties of a Novel Cephalosporin FR86521 Having Potent Activity Against Methicillin-resistant Staphylococcus aureus (MRSA)
Anti-cachectic Effect of FK317, a Novel Anti-cancer Agent, in Colon26 and LX-1 Models in Mice
FK317, a Novel Substituted Dihydrobenzoxazine, Exhibits Potent Antitumor Activity against Human Tumor Xenografts in Nude Mice
Different Effects of FK317 on Multidrug-resistant Tumor in vivo and in vitro
Cytotoxic Mechanisms of FK317, a New Class of Bioreductive Agent with Potent Antitumor Activity
A New Aromatase Inhibitor, FR901537 II.Pharmacological and Antitumor Effects
Use of a serum-based antifungal susceptibility assay to predict the in vivo efficacy of novel echinocandin compounds

スポンサーリンク